A critical advance in cancer study is occurring with the use of VHH fragments to re-engage mutated p53. This vital tumor protector protein is frequently lost in many forms of malignancies, leading uncontrolled cell https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research